NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 4.95% |
326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.65% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.57% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.31% |
ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.30% |
KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.28% |
ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 4.23% |
CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.03% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.97% |
SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.88% |
XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.82% |
SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 3.80% |
AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 3.45% |
DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.35% |
IART | Integra LifeSciences Holdings | Healthcare | Medical Devices | 3.28% |
EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 3.11% |